Cantor Fitzgerald’s Eric Johnston sees tactical short-term bounce in stocks
Eric Johnston, chief equity and macro strategist at Cantor Fitzgerald, said he believes stocks are in for a tactical ...
The Daily Hodl2d
Stock Market To Witness Rallies in Next One to Two Weeks, Predicts Wall Street’s Cantor Fitzgerald – Here’s Why
The financial services giant Cantor Fitzgerald is predicting the stock market will see rallies in the next one to two weeks.
ETF Daily News5d
Cantor Fitzgerald Reduces Earnings Estimates for Codexis
Cantor Fitzgerald has a “Overweight” rating and a $11.00 price objective on the stock. The consensus estimate for Codexis’ current full-year earnings is ($0.77) per share. Get Codexis alerts: ...
Investing5d
Cantor Fitzgerald sets Overweight rating on Protara stock
On Friday, Cantor Fitzgerald initiated coverage on Protara Therapeutics (NASDAQ:TARA) with an Overweight rating, indicating a positive outlook for the biopharmaceutical company’s stock.
ETF Daily News5d
FY2024 EPS Estimates for Exagen Lifted by Cantor Fitzgerald
Exagen Inc. (NASDAQ:XGN – Free Report) – Stock analysts at Cantor Fitzgerald increased their FY2024 EPS estimates for Exagen in a research note issued to investors on Monday, March 10th.
Business Insider5d
Protara Therapeutics initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Li Watsek initiated coverage of Protara Therapeutics (TARA) with an Overweight rating. Easily identify stocks' risks and opportunities. Discover stocks' market position ...